To ensure efficiency and security in a highly regulated environment, the pharmaceutical industry is using advanced analytics for drug and vaccine research and development.
Faced with global demand and strong worldwide competition to produce a COVID-19 vaccine, many companies had to accelerate digital transformation, rethink their strategy, and look for ways to improve their organization to develop, produce, package, and ship their vaccines in record time.
Pfizer, one of the world’s leaders in the fight against the COVID-19 pandemic, relies on TIBCO for its digital transformation. At the 2021 TIBCO Analytics Forum in May, Hamid Mehdizadeh, director of digital manufacturing intelligence at Pfizer, explained how TIBCO technologies are helping his company’s process optimization, innovation, and profitability.
Listen to TIBCO Specialist Olivier Lebret explain how analytics, real-time dashboards, and AI/ML predictive models are at the core of Pfizer’s digital manufacturing strategy.